0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(20):2082. doi:10.1001/jama.2014.15133.

Viewpoint |  FREE
Mahlon R. DeLong, MD; Alim-Louis Benabid, MD, PhD
JAMA. 2014;312(11):1093-1094. doi:10.1001/jama.2014.11132.

JAMA Revisited | 
Edward Livingston Hunt, M.D.; Leon H. Cornwall, M.D.
JAMA. 2014;311(16):1696. doi:10.1001/jama.2013.279467.

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;311(16):1686-1687. doi:10.1001/jama.2014.3323.

Review |  FREE
Barbara S. Connolly, MD; Anthony E. Lang, MD
JAMA. 2014;311(16):1670-1683. doi:10.1001/jama.2014.3654.
Includes: CME, Supplemental Content

Grand Rounds | 
W. Jeffrey Elias, MD; Binit B. Shah, MD
JAMA. 2014;311(9):948-954. doi:10.1001/jama.2014.1397.

From the JAMA Network | 
Danny Bega, MD; Dimitri Krainc, MD, PhD
JAMA. 2014;311(6):617-618. doi:10.1001/jama.2013.285516.

news@JAMA | 
JAMA. 2014;311(5):455. doi:10.1001/jama.2014.24.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2013;309(8):759. doi:10.1001/jama.2013.1276.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.267.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects
Nicolaas I. Bohnen, MD, PhD; Roger L. Albin, MD; Martijn L. T. M. Müller, PhD; et al.
JAMA Neurology
Original Investigation  | 
Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation–Positive Cohort
Michelle Beavan, MRCP(UK); Alisdair McNeill, PhD, MRCP(UK); Christos Proukakis, PhD, FRCP; et al.
JAMA Internal Medicine
Invited Commentary  | 
Finding Meaningful Patterns in Adverse Drug Event Reports
Joshua J. Gagne, PharmD, ScD
JAMA Internal Medicine
Invited Commentary  | 
Dopamine Receptor Agonist Drugs and Impulse Control Disorders
Howard D. Weiss, MD; Gregory M. Pontone, MD